Which of the following infants should receive monthly intramuscular palivizumab prophylaxis during the RSV season?

• A Healthy term-born 4-month-old attending daycare
• B Term-born 3-month-old whose sibling had RSV last year
• C Former 37-week infant with transient tachypnea of newborn, now 8 months old
• D Infant born at 32 weeks gestation, currently 4 months old, entering the RSV season ✓

Explanation

Palivizumab is given monthly during the RSV season to infants born at or before 35 weeks gestation who are younger than 6 months at the onset of the season, and to children under 2 years with hemodynamically significant heart disease or chronic lung disease of prematurity. Daycare attendance and household exposure are social risks but do not qualify a term infant for prophylaxis.

Reference: Nelson Textbook of Pediatrics, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.